BryoSphere Biotechnologies
Sustainable specialty chemical manufacturing using engineered moss
* Data source: Crunchbase
- Founded
- 2022
- Employees*
- 2-10
- Funding to Date*
- $275,000
- Website
- bryosphere.ca
"At BryoSphere Biotechnologies, we harness the power of moss to solve a critical skincare challenge: the manufacturing of complex, plant-derived compounds. Our pioneering technology makes these transformative ingredients accessible, revolutionizing skincare with innovative, effective solutions."
Moss has the genetic potential of land plants, with the scalable culture of algae
BryoSphere Biotechnologies uses moss plants and biotechnology techniques to synthesize rare, plant-derived specialty compounds. By harnessing the genetic information of a variety of plants, BryoSphere achieves the production of rare compounds with significantly higher yields compared to those found in their natural counterparts, thereby enhancing accessibility. Currently, BryoSphere is dedicated to the development of two key products: one for addressing skin hyperpigmentation in topical treatments, and another as an anti-cancer drug.
More Companies
